Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 238S · 10 late238 trades$60.26M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 8 | Vaughn Bryan TEVP and President, Diagnostics |  LHLABCORP HOLDINGS INC.Open-market sale · 10b5-1 plan | SELL | $108K 306 sh |
| Nov 5, 2026 traded Nov 3, 2026 |
| 49 | Way T LawrenceDirector |  CUBICustomers Bancorp, Inc.Open-market sale | SELL | $4.09M 48.8K sh | Nov 4, 2026 traded Oct 30, 2026 |
| 48 | Sing George LDirector |  REGNREGENERON PHARMACEUTICALS, INC.Open-market sale | SELL | $6.83M 7,073 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 44 | Sing George LDirector | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $2.58M 2,670 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 44 | Sing George LDirector | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $1.47M 1,522 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 44 | Larosa Joseph JEVP General Counsel and Secret | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $3.80M 3,939 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 44 | Sing George LDirector | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $4.18M 4,338 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 44 | Sing George LDirector | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $2.43M 2,522 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 42 | Murphy Robert MadisonDirector |  MUSAMurphy USA Inc.Open-market sale | SELL | $589K 1,000 sh | Nov 4, 2026 traded May 4, 2026 |
| 42 | Skeete Bernard MChief Accounting Officer |  VLTOVeralto CorpOpen-market sale | SELL | $170K 1,514 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 40 | Sing George LDirector | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $1.01M 1,040 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 40 | Sing George LDirector | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $1.18M 1,224 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 40 | Pope Daniel MDirector |  TYLTYLER TECHNOLOGIES INCOpen-market sale | SELL | $277K 680 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 40 | Olschan Brian SDirector, President and COO |  ACUACME UNITED CORPOpen-market sale | SELL | $982K 14.2K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 39 | Clay CraigSenior Advisor |  DFINDonnelley Financial Solutions, Inc.Open-market sale | SELL | $1.89M 28.1K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 39 | Treff Douglas JDirector |  CROXCrocs, Inc.Open-market sale | SELL | $1.10M 7,185 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 39 | Heyer Andrew RDirector |  OSWONESPAWORLD HOLDINGS LtdOpen-market sale | SELL | $183K 7,000 sh | Nov 4, 2026 traded Aug 20, 2026 |
| 39 | Clay CraigSenior Advisor | DFINDonnelley Financial Solutions, Inc. Open-market sale | SELL | $1.45M 21.5K sh | Nov 4, 2026 traded Nov 3, 2026 |
| 39 | Clay CraigSenior Advisor | DFINDonnelley Financial Solutions, Inc. Open-market sale | SELL | $1.45M 21.4K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 38 | Murphy Robert MadisonDirector | MUSAMurphy USA Inc. Open-market sale | SELL | $624K 1,000 sh | Nov 4, 2026 traded Jul 29, 2026 |
| 38 | Chybowski Joseph M.PRESIDENT & CFO |  BWBBridgewater Bancshares IncOpen-market sale | SELL | $197K 9,651 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 38 | Lindquist Scott REVP & CFO |  CNACNA FINANCIAL CORPOpen-market sale | SELL | $1.12M 23.6K sh | Nov 4, 2026 traded Nov 3, 2026 |
| 38 | Bichara GuillermoExec VP & Chief Legal Officer |  LINLINDE PLCOpen-market sale | SELL | $4.85M 9,350 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 37 | Sing George LDirector | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $519K 540 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 37 | Larosa Joseph JEVP General Counsel and Secret | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $509K 527 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 37 | Murphy Susan HDirector | ACUACME UNITED CORP Open-market sale | SELL | $194K 2,890 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 36 | Bradley Mark ChristopherChief Development Officer |  ALMSALUMIS INC.Open-market sale | SELL | $4,062 623 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 36 | Schroer John R.Chief Financial Officer | ALMSALUMIS INC. Open-market sale | SELL | $5,177 794 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 36 | Hardiman Roy C.Chief Business & Strategy Ofcr | ALMSALUMIS INC. Open-market sale | SELL | $4,251 652 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 36 | Murray CiaranDirector |  ICLRICON PLCOpen-market sale | SELL | $710K 3,452 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 36 | Pangali SanamChief Legal Officer | ALMSALUMIS INC. Open-market sale | SELL | $2,165 332 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 36 | Turner KamiChief Accounting Officer | DFINDonnelley Financial Solutions, Inc. Open-market sale | SELL | $406K 6,100 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 36 | Goldstein David MChief Scientific Officer | ALMSALUMIS INC. Open-market sale | SELL | $4,101 629 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 36 | Turner KamiChief Accounting Officer | DFINDonnelley Financial Solutions, Inc. Open-market sale | SELL | $406K 6,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 36 | Drappa JornChief Medical Officer | ALMSALUMIS INC. Open-market sale | SELL | $3,866 593 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 35 | Mulroy Molly AEVP & Chief Admin Officer |  WECWEC ENERGY GROUP, INC.Open-market sale | SELL | $549K 4,695 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 35 | Berho Carranza DiegoChief Portfolio Officer |  VTMXVesta Real Estate Corporation, S.A.B. de C.V.Open-market sale | SELL | $109K 30.0K sh | Nov 4, 2026 traded Nov 3, 2026 |
| 34 | Boersma TravisDirector, Executive Chairman of Board, 10% Owner |  BROSDutch Bros Inc.Open-market sale · 10b5-1 plan | SELL | $11.31M 256.7K sh | Nov 4, 2026 traded Nov 3, 2026 |
| 34 | Boersma TravisDirector, Executive Chairman of Board, 10% Owner | BROSDutch Bros Inc. Open-market sale · 10b5-1 plan | SELL | $22.25M 499.0K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 34 | Boersma TravisDirector, Executive Chairman of Board, 10% Owner | BROSDutch Bros Inc. Open-market sale · 10b5-1 plan | SELL | $11.88M 266.4K sh | Nov 4, 2026 traded Nov 4, 2026 |
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
IBEXIBEX LtdSep 8 – Sep 166 insiders$2.66M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 36 insiders$1.24M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
BCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K